<DOC>
	<DOCNO>NCT00654784</DOCNO>
	<brief_summary>Idebenone synthetic analogue coenzyme Q10 powerful antioxidant essential constituent process energy production cellular level . It protect mitochondrion oxidative damage boost impaired function . It think mechanism slow decline heart function part disease process Duchenne Muscular Dystrophy ( DMD ) . It possible patient may benefit term muscle strength respiratory function . This pilot trial design investigate .</brief_summary>
	<brief_title>Efficacy Tolerability Idebenone Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Idebenone</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Patients 8 16 year age time enrolment Male Presence cardiac involvement/dysfunction , define abnormal peak systolic strain leave ventricle ( LV ) inferolateral wall Confirmed diagnosis DMD ( frame dystrophin gene deletion OR absent/ &lt; 5 % dystrophin protein muscle biopsy ; clinical picture consistent typical DMD ) If chronic glucocorticosteroids treatment ( deflazacort , prednisone ) DMD ( disease ) ( i.e . concomitant medication ) : dosage must stable ( unchanged ) 6 month prior inclusion If chronic medication DMD associate cardiomyopathy ( Î²blocker , diuretic ) : dosage must stable ( unchanged ) 3 month prior inclusion Ability provide reproducible repeat quantitative muscle test ( QMT ) upper limb score within 15 % first assessment score ( Visit1/Day 1 versus Screening Visit Symptomatic cardiomyopathy heart failure Asymptomatic severe cardiac dysfunction baseline ( Screening ) evaluation : Fractional shortening ( FS ) &lt; 20 % and/or Ejection fraction ( EF ) &lt; 40 % Use ACEinhibitors Previous history ventricular arrhythmia ( isolated ventricular extrasystole ) ; ventricular arrhythmia present Screening Previous ( 6 month less ) participation therapeutic trial DMD Use coenzymeQ10 , idebenone , creatine , glutamine , oxatomide , herbal medicine within last 6 month History significant concomitant illness significant impairment renal hepatic function Known individual hypersensitivity idebenone</criteria>
	<gender>Male</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Duchenne Muscular Dystrophy</keyword>
	<keyword>DMD</keyword>
	<keyword>Duchenne</keyword>
</DOC>